Newcastle_NP Disease_NP Virus_NP V_NN Protein_NP Is_VBZ a_DT Determinant_NP of_IN Host_NP Range_NP Restriction_NP It_PP has_VBZ been_VBN demonstrated_VBN that_IN the_DT V_CD protein_NN of_IN Newcastle_NP disease_NN virus_NN (_( NDV_NP )_) functions_NNS as_IN an_DT alpha/beta_NN interferon_NN (_( IFN-alpha/beta_NP )_) antagonist_NN (_( M._NP S._NP Park_NP ,_, M._NP L._NP Shaw_NP ,_, J._NP Munoz-Jordan_NP ,_, J._NP F._NP Cros_NP ,_, T._NP Nakaya_NP ,_, N._NP Bouvier_NP ,_, P._NP Palese_NP ,_, A._NP Garcia-Sastre_NP ,_, and_CC C._NP F._NP Basler_NP ,_, J._NP Virol_NP ._SENT 77:1501-1511_CD ,_, 2003_CD )_) ._SENT We_PP now_RB show_VBP that_IN the_DT NDV_NP V_NN protein_NN plays_VBZ an_DT important_JJ role_NN in_IN host_NN range_NN restriction_NN ._SENT In_IN order_NN to_TO study_VB V_CD functions_NNS in_IN vivo_JJ ,_, recombinant_JJ NDV_NP (_( rNDV_NP )_) mutants_NNS ,_, defective_JJ in_IN the_DT expression_NN of_IN the_DT V_CD protein_NN ,_, were_VBD generated_VBN ._SENT These_DT rNDV_NP mutants_NNS grow_VBP poorly_RB in_IN both_DT embryonated_JJ chicken_NN eggs_NNS and_CC chicken_NN embryo_NN fibroblasts_NNS (_( CEFs_NP )_) compared_VBD to_TO the_DT wild-type_NN (_( wt_NN )_) rNDV_NP ._SENT However_RB ,_, insertion_NN of_IN the_DT NS1_JJ gene_NN of_IN influenza_NN virus_NN A/PR8/34_NP into_IN the_DT NDV_NP V(-)_JJ genome_NN [_SYM rNDV_NP V(-)/NS1_NP ]_SYM restores_VBZ impaired_JJ growth_NN to_TO wt_NN levels_NNS in_IN embryonated_JJ chicken_NN eggs_NNS and_CC CEFs_NNS ._SENT These_DT data_NNS indicate_VBP that_IN for_IN viruses_NNS infecting_VBG avian_JJ cells_NNS ,_, the_DT NDV_NP V_CD protein_NN and_CC the_DT influenza_NN NS1_JJ protein_NN are_VBP functionally_RB interchangeable_JJ ,_, even_RB though_IN there_EX are_VBP no_DT sequence_NN similarities_NNS between_IN the_DT two_CD proteins_NNS ._SENT Interestingly_RB ,_, in_IN human_JJ cells_NNS ,_, the_DT titer_NN of_IN wt_NP rNDV_NP is_VBZ 10_CD times_NNS lower_JJR than_IN that_DT of_IN rNDV_NP V(-)/NS1_NP ._SENT Correspondingly_RB ,_, the_DT level_NN of_IN IFN_NP secreted_VBD by_IN human_JJ cells_NNS infected_VBN with_IN wt_NP rNDV_NP is_VBZ much_RB higher_JJR than_IN that_DT secreted_VBN by_IN cells_NNS infected_VBN with_IN the_DT NS1-expressing_NP rNDV_NP ._SENT This_DT suggests_VBZ that_IN the_DT IFN_NP antagonist_NN activity_NN of_IN the_DT NDV_NP V_NN protein_NN is_VBZ species_NN specific_JJ ._SENT Finally_RB ,_, the_DT NDV_NP V_NN protein_NN plays_VBZ an_DT important_JJ role_NN in_IN preventing_VBG apoptosis_NN in_IN a_DT species-specific_JJ manner_NN ._SENT The_DT rNDV_NN defective_JJ in_IN V_CD induces_VBZ apoptotic_JJ cell_NN death_NN more_RBR rapidly_RB in_IN CEFs_NNS than_IN does_VBZ wt_NP rNDV_NP ._SENT Taken_VBN together_RB ,_, these_DT data_NNS suggest_VBP that_IN the_DT host_NN range_NN of_IN NDV_NP is_VBZ limited_VBN by_IN the_DT ability_NN of_IN its_PP$ V_CD protein_NN to_TO efficiently_RB prevent_VB innate_JJ host_NN defenses_NNS ,_, such_JJ as_IN the_DT IFN_NP response_NN and_CC apoptosis_NN ._SENT Newcastle_NP disease_NN virus_NN (_( NDV_NP )_) ,_, an_DT avian_JJ paramyxovirus_NN ,_, is_VBZ classified_VBN as_IN the_DT only_JJ member_NN of_IN the_DT genus_NN Avulavirus_NP belonging_VBG to_TO the_DT family_NN Paramyxoviridae_NNS within_IN the_DT order_NN Mononegavirales_NP ._SENT NDV_NP is_VBZ an_DT economically_RB important_JJ pathogen_NN ,_, since_IN periodic_JJ outbreaks_NNS affect_VBP the_DT poultry_NN industry_NN ._SENT NDV_NP is_VBZ also_RB considered_VBN a_DT potential_JJ oncolytic_JJ agent_NN in_IN the_DT treatment_NN of_IN cancer_NN because_IN it_PP can_MD selectively_RB kill_VB tumor_NN cells_NNS ._SENT NDV_NP isolates_NNS are_VBP categorized_VBN as_IN velogenic_JJ (_( highly_RB virulent_JJ )_) ,_, mesogenic_JJ (_( intermediate_JJ )_) ,_, or_CC lentogenic_JJ (_( nonvirulent_JJ )_) ,_, depending_VBG on_IN the_DT severity_NN of_IN the_DT disease_NN they_PP cause_VBP ._SENT A_DT critical_JJ molecular_JJ determinant_NN for_IN the_DT pathogenicity_NN of_IN NDV_NP appears_VBZ to_TO be_VB the_DT cleavage_NN site_NN of_IN the_DT fusion_NN (_( F_NN )_) protein_NN ._SENT The_DT NDV_NP genome_NN is_VBZ 15,186_CD nucleotides_NNS long_RB ,_, and_CC it_PP consists_VBZ of_IN six_CD transcriptional_JJ units_NNS that_WDT encode_VBP the_DT nucleocapsid_JJ protein_NN (_( NP_NP )_) ,_, phosphoprotein_NN (_( P_NN )_) ,_, matrix_NN protein_NN (_( M_NP )_) ,_, F_NN protein_NN ,_, hemagglutinin_NN protein_NN (_( HN_NP )_) ,_, and_CC the_DT polymerase_NN protein_NN (_( L_NP )_) ._SENT Two_CD additional_JJ proteins_NNS ,_, V_CD and_CC W_NP ,_, are_VBP expressed_VBN by_IN mRNAs_NNS ,_, which_WDT are_VBP derived_VBN from_IN the_DT P_NN gene_NN via_IN RNA_NP editing_VBG ._SENT These_DT V_NN and_CC W_NN proteins_NNS share_VBP their_PP$ amino_NN (N)-terminal_JJ domains_NNS with_IN the_DT P_NN protein_NN and_CC vary_VBP at_IN their_PP$ carboxy_NN (_( C_NP )_) termini_NNS ._SENT The_DT NDV_NP V_CD protein_NN ,_, similar_JJ to_TO other_JJ paramyxovirus_NN V_CD proteins_NNS ,_, has_VBZ a_DT cysteine-rich_JJ C-terminal_JJ domain_NN which_WDT binds_VBZ two_CD atoms_NNS of_IN Zn2+_NP ._SENT It_PP has_VBZ been_VBN demonstrated_VBN that_IN plasmid-mediated_JJ expression_NN of_IN the_DT NDV_NP V_CD protein_NN or_CC of_IN its_PP$ C-terminal_JJ domain_NN inhibits_VBZ the_DT alpha/beta_NN interferon_NN (_( IFN-alpha/beta_NP )_) response_NN ._SENT We_PP now_RB show_VBP ,_, using_VBG reverse_JJ genetics_NNS ,_, that_IN this_DT IFN_NP antagonist_NN activity_NN is_VBZ important_JJ for_IN virus_NN replication_NN in_IN vivo_RB ._SENT In_IN addition_NN ,_, we_PP found_VBD that_IN V_CD activity_NN is_VBZ restricted_VBN to_TO avian_JJ hosts_NNS ._SENT Moreover_RB ,_, we_PP show_VBP that_IN the_DT NDV_NP V_CD protein_NN and_CC the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN are_VBP functionally_RB interchangeable_JJ and_CC that_IN the_DT host_NN restriction_NN of_IN NDV_NP can_MD be_VB partially_RB overcome_VBN by_IN the_DT expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN ._SENT Several_JJ viruses_NNS have_VBP evolved_VBN strategies_NNS to_TO regulate_VB IFN-related_JJ responses_NNS through_IN the_DT synthesis_NN of_IN IFN-alpha/beta_NP antagonists_NNS ._SENT Specifically_RB ,_, influenza_NN viruses_NNS and_CC paramyxoviruses_NNS use_VBP distinct_JJ virus-specific_JJ proteins_NNS to_TO counteract_VB the_DT IFN_NP response_NN ._SENT Some_DT influenza_NN viruses_NNS and_CC paramyxoviruses_NNS ,_, including_VBG simian_JJ virus_NN 5_CD (_( SV5_NP )_) and_CC respiratory_JJ syncytial_JJ virus_NN ,_, have_VBP been_VBN shown_VBN to_TO inhibit_VB the_DT IFN_NP response_NN in_IN a_DT species-specific_JJ manner_NN ,_, suggesting_VBG that_IN the_DT IFN-alpha/beta_NP antagonist_NN activity_NN may_MD affect_VB the_DT host_NN range_NN restriction_NN of_IN viruses_NNS ._SENT It_PP was_VBD previously_RB shown_VBN that_IN IFN-alpha/beta_NP cytokines_NNS are_VBP mediators_NNS of_IN apoptotic_JJ death_NN in_IN virus-infected_JJ cells_NNS ._SENT Successful_JJ viral_JJ replication_NN requires_VBZ evasion_NN of_IN proapoptotic_JJ mechanisms_NNS in_IN order_NN to_TO achieve_VB efficient_JJ virus_NN production_NN and_CC spread_NN of_IN progeny_NN ._SENT Recently_RB ,_, it_PP was_VBD shown_VBN that_IN a_DT mutant_NN of_IN SV5_NP ,_, a_DT virus_NN closely_RB related_VBN to_TO NDV_NP ,_, lacking_VBG the_DT C-terminal_JJ cysteine-rich_JJ domain_NN of_IN its_PP$ V_CD protein_NN induced_VBD increased_VBN cytopathic_JJ effects_NNS (_( CPE_NP )_) in_IN infected_JJ cells_NNS ._SENT In_IN addition_NN ,_, SV5_NP requires_VBZ expression_NN of_IN the_DT small_JJ hydrophobic_JJ (_( SH_NP )_) gene_NN to_TO efficiently_RB prevent_VB apoptosis_NN induced_VBN by_IN viral_JJ infection_NN ._SENT In_IN this_DT context_NN ,_, it_PP should_MD be_VB noted_VBN that_IN NDV_NP does_VBZ not_RB code_VB for_IN an_DT SH_NP protein_NN ._SENT Here_RB ,_, we_PP show_VBP through_IN the_DT use_NN of_IN recombinant_JJ NDV_NP (_( rNDV_NP )_) mutants_NNS defective_JJ in_IN V_CD protein_NN expression_NN that_IN the_DT NDV_NP V_NN protein_NN plays_VBZ an_DT important_JJ role_NN in_IN preventing_VBG IFN_NP responses_NNS and_CC apoptosis_NN in_IN chicken_NN cells_NNS ,_, but_CC not_RB in_IN human_JJ cells_NNS ._SENT These_DT species-specific_JJ effects_NNS may_MD provide_VB a_DT partial_JJ explanation_NN for_IN the_DT limited_JJ host_NN range_NN of_IN NDV_NP ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Chicken_NP embryo_NN fibroblasts_NNS (_( CEFs_NP )_) were_VBD prepared_VBN from_IN 10-day-old_JJ specific-pathogen-free_JJ chicken_NN embryos_NNS (_( Charles_NP River_NP SPAFAS_NP ,_, North_NP Franklin_NP ,_, Conn._NP )_) ._SENT The_DT CEFs_NP were_VBD maintained_VBN in_IN minimum_JJ essential_JJ medium_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT Vero_NP ,_, Hep-2_NP ,_, and_CC A549_NP cells_NNS were_VBD maintained_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP medium_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT rNDV_NN and_CC rNDV-GFP_NN viruses_NNS were_VBD previously_RB generated_VBN by_IN reverse_JJ genetics_NNS from_IN the_DT corresponding_JJ full-length_JJ cDNA_NN copies_NNS derived_VBN from_IN the_DT NDV_NP Hitchner_NP B1_NP strain_NN ._SENT Construction_NN of_IN plasmids_NNS ._SENT |_SYM pNDV/B1_NN containing_VBG the_DT full-length_JJ cDNA_NN of_IN the_DT lentogenic_JJ NDV_NP Hitchner_NP B1_NP strain_NN has_VBZ been_VBN described_VBN previously_RB ._SENT To_TO construct_VB rNDV_NP V(-)2ch_NP ,_, we_PP substituted_VBD 2_CD nucleotides_NNS in_IN the_DT RNA-editing_NP locus_NN of_IN the_DT P_NN gene_NN ._SENT First_RB ,_, the_DT SacII-XbaI_NP NDV_NP cDNA_NN fragment_NN was_VBD subcloned_VBN into_IN plasmid_NP pSL1180_NP (_( Amersham_NP Pharmacia_NP Biotech_NP )_) ,_, and_CC then_RB site-directed_JJ mutagenesis_NN PCR_NP was_VBD performed_VBN using_VBG the_DT primers_NNS Vko(+)_NP (_( 5'-ATC_NP GTC_NP CAA_NP TGC_NP TAA_NP gAA_NP aGG_NN CCC_NP ATG_NP GTC_NP G_NP )_) and_CC Vko(-)_NP (_( 5'-CGA_NP CCA_NP TGG_NP GCC_NP tTT_NP cTT_NP AGC_NP ATT_NP GGA_NP CGA_NP T_NN )_) (_( the_DT lowercase_JJ letters_NNS represent_VBP the_DT mutated_VBN nucleotides_NNS )_) ._SENT The_DT mutated_VBN fragment_NN was_VBD then_RB reintroduced_VBN into_IN the_DT full-length_JJ NDV_NP clone_NN ._SENT pNDV_NP V(-)stop_NP has_VBZ a_DT full-length_JJ cDNA_NN copy_NN of_IN a_DT mutated_VBN NDV_NP genome_NN encoding_VBG a_DT truncated_JJ V_CD protein_NN ._SENT In_IN order_NN to_TO selectively_RB block_VB the_DT expression_NN of_IN the_DT C_NP terminus_NN of_IN the_DT NDV_NP V_CD protein_NN ,_, a_DT stop_NN codon_NN was_VBD introduced_VBN into_IN the_DT open_JJ reading_NN frame_NN (_( ORF_NP )_) of_IN V_CD using_VBG the_DT following_VBG primers_NNS :_: Vstop(+)_NP (_( 5'-AAG_NP GGC_NP CCA_NP TGG_NP TCt_NP AGC_NP CCC_NP CA_NP )_) ,_, containing_VBG an_DT ApaI_NP site_NN (_( underlined_VBN )_) ,_, and_CC Vstop(-)_NP (_( 5'-TGC_NP CGC_NP TTC_NP TAG_NP AGT_NP TGG_NP ACC_NP TTG_NP )_) ,_, containing_VBG an_DT XbaI_NP site_NN (_( underlined_VBN )_) ._SENT The_DT lowercase_JJ letter_NN represents_VBZ the_DT mutation_NN introducing_VBG the_DT stop_NN codon_NN in_IN V_CD without_IN affecting_VBG the_DT P_NN frame_NN ._SENT To_TO insert_VB the_DT NS1_JJ genes_NNS of_IN the_DT influenza_NN A/PR/8/34_NN virus_NN or_CC the_DT NDV_NP V_CD gene_NN as_IN an_DT extra_JJ transcriptional_JJ unit_NN into_IN the_DT NDV_NP mutant_JJ genomes_NNS ,_, an_DT NruI_NP site_NN was_VBD introduced_VBN between_IN the_DT HN_NP and_CC L_NP genes_NNS of_IN rNDV_NP V(-)2ch_NP and_CC rNDV_NP V(-)stop_NP ._SENT A_DT pNDV/B1_JJ fragment_NN digested_VBN with_IN SpeI_NP and_CC BsiWI_NP was_VBD subcloned_VBN into_IN pSL1180_NN ,_, and_CC then_RB site-directed_JJ mutagenesis_NN was_VBD performed_VBN using_VBG the_DT primers_NNS SDM_NP Nru(+)_NP (_( 5'-AAC_NP AGC_NP TCA_NP TGG_NP TTC_NP GCG_NP ATA_NP CGG_NP GTA_NP GGA_NP CA_NP )_) and_CC SDM_NP Nru(-)_NP (_( 5'-TGT_NP CCT_NP ACC_NP CGT_NP ATC_NP GCG_NP AAC_NP CAT_NP GAG_NP CTG_NP TT_NP )_) ,_, containing_VBG an_DT NruI_NP site_NN (_( underlined_VBN )_) ._SENT A_DT new_JJ transcriptional_JJ unit_NN encoding_VBG the_DT NS1_NP or_CC V_CD protein_NN was_VBD then_RB inserted_VBN between_IN the_DT HN_NP and_CC L_NP genes_NNS using_VBG the_DT NruI_NP restriction_NN site_NN ._SENT Three_CD nucleotides_NNS (_( lowercase_JJ )_) in_IN the_DT RNA-editing_NP locus_NN of_IN the_DT new_JJ V_NN gene_NN were_VBD changed_VBN to_TO block_VB RNA_NP editing_VBG (_( UUUUUCCCC_NP to_TO UUcUUuCCgC_NP )_) ._SENT Generation_NN of_IN rNDV_NN mutants_NNS ._SENT |_SYM rNDV_NP mutants_NNS were_VBD generated_VBN using_VBG a_DT reverse_JJ genetics_NN system_NN established_VBN previously_RB ._SENT Briefly_RB ,_, Hep-2_NP or_CC A549_NP cells_NNS in_IN six-well_NN plates_NNS were_VBD infected_VBN with_IN MVA-T7_JJ and_CC then_RB transfected_JJ with_IN rNDV_NP V(-)2ch_NP ,_, rNDV_NP V(-)stop_NP ,_, rNDV_NP V(-)/V_NP ,_, or_CC rNDV_NP V(-)/NS1_NP together_RB with_IN pTM1-NP_NN ,_, pTM1-P_NN ,_, and_CC pTM1-L_NN ._SENT After_IN overnight_JJ incubation_NN ,_, the_DT transfected_JJ cells_NNS were_VBD cocultured_VBN with_IN CEF_NP cells_NNS ,_, and_CC 3_CD or_CC 4_CD days_NNS posttransfection_NN ,_, the_DT supernatants_NNS were_VBD injected_VBN into_IN the_DT allantoic_JJ cavities_NNS of_IN 7-_CD or_CC 8-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ._SENT Allantoic_JJ fluids_NNS were_VBD harvested_VBN 3_CD or_CC 4_CD days_NNS postinjection_NN ,_, and_CC viral_JJ growth_NN was_VBD confirmed_VBN by_IN hemagglutination_NN assay_NN or_CC by_IN infection_NN immunofluorescence_NN assay_NN (_( IFA_NP )_) in_IN freshly_RB infected_JJ Vero_NP cells_NNS ._SENT The_DT insertion_NN of_IN the_DT new_JJ transcriptional_JJ units_NNS and_CC the_DT introduction_NN of_IN the_DT mutations_NNS were_VBD confirmed_VBN by_IN reverse_JJ transcription-PCR_NN followed_VBN by_IN sequencing_VBG analysis_NN ._SENT Viral_JJ growth_NN kinetics_NNS ._SENT |_SYM Embryonated_JJ chicken_NN eggs_NNS were_VBD inoculated_VBN with_IN nonrecombinant_JJ wild-type_NN (_( wt_NN )_) NDV_NP ,_, wt_NP rNDV_NP ,_, or_CC rNDV_NP mutants_NNS (_( 100_CD TCID50/egg_NN )_) ._SENT Monolayers_NNS of_IN CEFs_NP and_CC Vero_NP ,_, Hep-2_NP ,_, and_CC A549_NP cells_NNS were_VBD infected_VBN with_IN each_DT virus_NN at_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 0.01_CD ._SENT Viral_JJ growth_NN was_VBD analyzed_VBN at_IN different_JJ time_NN points_NNS after_IN infection_NN ._SENT The_DT 50_CD %_NN tissue_NN culture_NN infective_JJ dose_NN (_( TCID50_NP )_) of_IN each_DT virus_NN present_NN in_IN the_DT allantoic_JJ fluid_NN or_CC in_IN cell_NN supernatants_NNS was_VBD determined_VBN by_IN IFA_NP ._SENT For_IN this_DT purpose_NN ,_, 96-well_NN plates_NNS containing_VBG Vero_NP cells_NNS were_VBD infected_VBN with_IN serial_JJ 10-fold_NN dilutions_NNS of_IN the_DT samples_NNS ,_, and_CC the_DT presence_NN of_IN NDV_NP was_VBD determined_VBN by_IN IFA_NP using_VBG an_DT anti-NDV_NP rabbit_NN polyclonal_JJ serum_NN ._SENT IFAs_NP ._SENT |_SYM For_IN the_DT analysis_NN of_IN viral_JJ growth_NN and_CC viral_JJ protein_NN expression_NN ,_, confluent_JJ CEFs_NNS were_VBD infected_VBN with_IN the_DT recombinant_JJ virus_NN (_( four_CD wells_NNS per_IN dilution_NN )_) ._SENT The_DT cells_NNS were_VBD incubated_VBN for_IN 2_CD days_NNS and_CC fixed_VBN with_IN 2.5_CD %_NN formaldehyde_NN containing_VBG 0.1_CD %_NN Triton_NP X-100_NP ._SENT The_DT cells_NNS were_VBD incubated_VBN with_IN anti-NDV_NP rabbit_NN polyclonal_JJ serum_NN or_CC anti-influenza_NN virus_NN NS1_JJ rabbit_NN serum_NN and_CC then_RB were_VBD washed_VBN and_CC stained_VBN with_IN fluorescein_NN isothiocyanate-conjugated_JJ anti-rabbit_NN immunoglobulins_NNS (_( DAKO_NP )_) ._SENT Viral_JJ protein_NN expression_NN was_VBD examined_VBN by_IN fluorescence_NN microscopy_NN ._SENT Quantification_NN of_IN IFN_NP production_NN from_IN infected_JJ cells_NNS ._SENT |_SYM To_TO measure_VB IFN_NP production_NN ,_, cells_NNS were_VBD infected_VBN with_IN rNDV_NP or_CC rNDV_NP mutants_NNS at_IN an_DT MOI_NP of_IN 1_CD ._SENT Supernatants_NNS from_IN infected_JJ cells_NNS were_VBD harvested_VBN 24_CD h_NN postinfection_NN (_( p.i._JJ )_) and_CC then_RB treated_VBN with_IN UV_NP light_NN for_IN 7_CD min_NN to_TO inactivate_VB the_DT infectivity_NN of_IN the_DT virus_NN ._SENT Serial_JJ 10-fold_NN dilutions_NNS of_IN UV-treated_JJ supernatants_NNS were_VBD added_VBN to_TO fresh_JJ Vero_NP cells_NNS or_CC CEFs_NNS ._SENT The_DT UV-treated_JJ supernatants_NNS were_VBD removed_VBN 20_CD h_NN posttreatment_NN ,_, and_CC then_RB the_DT cells_NNS were_VBD infected_VBN with_IN rNDV-GFP_NN at_IN an_DT MOI_NP of_IN 1_CD ._SENT Green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) expression_NN was_VBD analyzed_VBN by_IN fluorescence_NN microscopy_NN 24_CD h_NN p.i._NN The_DT ability_NN of_IN the_DT UV-treated_JJ supernatants_NNS to_TO inhibit_VB rNDV-GFP_NN replication_NN is_VBZ indicative_JJ of_IN the_DT antiviral_JJ action_NN of_IN the_DT IFN_NP present_NN in_IN the_DT sample_NN ._SENT DNA_NP fragmentation_NN and_CC Hoechst_NP staining_VBG ._SENT |_SYM The_DT extent_NN of_IN apoptosis_NN was_VBD estimated_VBN by_IN measuring_VBG the_DT degree_NN of_IN DNA_NN fragmentation_NN ._SENT Briefly_RB ,_, cells_NNS were_VBD harvested_VBN and_CC lysed_VBN with_IN lysis_NN buffer_NN (_( 10_CD mM_NP EDTA_NP ,_, 50_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 0.5_CD %_NN sodium_NN lauryl_NN sarcosine_NN )_) containing_VBG 100_CD mug_NN of_IN proteinase_NN K/ml_NP at_IN 55C_NP for_IN 2_CD h._NNS The_DT DNA_NN was_VBD extracted_VBN with_IN phenol-chloroform_NN and_CC precipitated_VBD with_IN ethanol_NN ._SENT After_IN RNA_NP was_VBD removed_VBN by_IN RNase_NP treatment_NN ,_, the_DT DNA_NN was_VBD analyzed_VBN by_IN 2_CD %_NN agarose_NN gel_NN electrophoresis_NN to_TO visualize_VB the_DT fragmented_JJ DNA_NN ._SENT For_IN observation_NN of_IN the_DT morphologies_NNS of_IN infected_JJ cell_NN nuclei_NNS ,_, the_DT infected_JJ cells_NNS were_VBD fixed_VBN with_IN methanol_NN containing_VBG 10_CD %_NN formaldehyde_NN and_CC stained_VBN with_IN the_DT DNA-binding_NP dye_NN Hoechst_NP 33258_CD ._SENT Terminal_JJ deoxynucleotidyltransferase-mediated_JJ dUTP-fluorescein_NN isothiocyanate_NN nick_NN end_NN labeling_VBG (_( TUNEL_NP )_) staining_VBG ._SENT |_SYM CEFs_NP or_CC Hep-2_NP cells_NNS were_VBD infected_VBN with_IN wt_NP rNDV_NP or_CC rNDV_NP mutants_NNS at_IN an_DT MOI_NP of_IN 1_CD ._SENT The_DT cells_NNS were_VBD fixed_VBN at_IN different_JJ time_NN points_NNS with_IN 4_CD %_NN paraformaldehyde_NN for_IN 1_CD h_NN at_IN room_NN temperature_NN and_CC then_RB permeabilized_VBN by_IN adding_VBG 0.1_CD %_NN Triton_NP X-100_NP in_IN 0.1_CD %_NN sodium_NN citrate_NN on_IN ice_NN for_IN 2_CD min_NN ._SENT Terminal_JJ transferase_NN was_VBD used_VBN to_TO label_VB free_JJ 3'OH_JJ ends_NNS in_IN genomic_JJ DNA_NN with_IN fluorescein-dUTP_NN as_IN described_VBN in_IN the_DT manufacturer_NN 's_POS manual_NN (_( in_IN situ_NN cell_NN death_NN detection_NN kit_NN ,_, fluorescein_NN ;_: Roche_NP )_) ._SENT The_DT nicked_VBN fluorescence-labeled_JJ DNA_NN was_VBD detected_VBN by_IN fluorescence_NN microscopy_NN ._SENT Generation_NN of_IN an_DT NDV_NP editing-defective_JJ mutant_NN ._SENT |_SYM It_PP was_VBD previously_RB found_VBN that_DT expression_NN of_IN the_DT V_CD protein_NN of_IN NDV_NP prevents_VBZ the_DT activation_NN of_IN the_DT IFN-alpha/beta_NP response_NN in_IN plasmid-transfected_JJ cells_NNS ._SENT In_IN order_NN to_TO determine_VB whether_IN the_DT NDV_NP V_CD protein_NN also_RB mediates_VBZ the_DT evasion_NN of_IN the_DT IFN_NP response_NN during_IN NDV_NP infection_NN ,_, we_PP generated_VBD an_DT rNDV_NN defective_JJ in_IN V_CD protein_NN expression_NN by_IN inactivating_VBG the_DT RNA-editing_NP signal_NN responsible_JJ for_IN V_CD mRNA_JJ synthesis_NN [_SYM rNDV_NP V(-)2ch_NP ]_SYM ._SENT It_PP has_VBZ been_VBN shown_VBN that_IN three_CD P_NN gene-derived_NN proteins_NNS with_IN identical_JJ N-terminal_JJ sequences_NNS ,_, P_NN ,_, V_CD ,_, and_CC W_NP ,_, are_VBP produced_VBN in_IN wt_JJ NDV-infected_JJ cells_NNS at_IN frequencies_NNS of_IN similar68_NN ,_, 29_CD ,_, and_CC 2_CD %_NN ,_, respectively_RB ._SENT However_RB ,_, the_DT level_NN of_IN V_CD protein_NN expression_NN from_IN an_DT NDV_NP editing-defective_JJ mutant_NN containing_VBG a_DT single-nucleotide_NN change_NN in_IN the_DT RNA-editing_NP locus_NN was_VBD <2_JJ %_NN ._SENT In_IN spite_NN of_IN repeated_JJ egg_NN passages_NNS ,_, NDV_NP V(-)2ch_NP did_VBD not_RB grow_VB to_TO detectable_JJ hemagglutinin_NN titers_NNS ,_, but_CC virus_NN could_MD be_VB detected_VBN by_IN IFA_NP when_WRB allantoic_JJ fluids_NNS were_VBD used_VBN to_TO infect_VB cultured_JJ cells_NNS (_( not_RB shown_VBN )_) ._SENT These_DT data_NNS indicated_VBD that_IN this_DT mutant_JJ NDV_NP was_VBD compromised_VBN for_IN replication_NN in_IN eggs_NNS ._SENT In_IN order_NN to_TO further_RBR analyze_VB the_DT replication_NN properties_NNS of_IN rNDV_NP V(-)2ch_NP ,_, we_PP conducted_VBD multicycle_NN growth_NN kinetics_NN studies_NNS in_IN CEFs_NP and_CC Vero_NP ,_, Hep-2_NP ,_, and_CC A549_NP cells_NNS ,_, as_RB well_RB as_RB in_IN 6-_CD and_CC 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ._SENT Supernatants_NNS from_IN infected_JJ cell_NN cultures_NNS and_CC the_DT allantoic_JJ fluid_NN from_IN embryonated_JJ eggs_NNS were_VBD harvested_VBN every_DT 24_CD h_NN for_IN 3_CD days_NNS ._SENT NDV_NP titers_NNS were_VBD determined_VBN by_IN measuring_VBG the_DT TCID50_NP in_IN Vero_NP cells_NNS ._SENT The_DT titers_NNS of_IN rNDV_NP V(-)2ch_NP grown_VBN in_IN CEFs_NP and_CC in_IN 10-day_JJ old_JJ embryonated_JJ chicken_NN eggs_NNS were_VBD 1,000-_CD and_CC 10,000-fold_NN lower_JJR ,_, respectively_RB ,_, than_IN those_DT of_IN wt_NP rNDV_NP ._SENT However_RB ,_, in_IN Vero_NP cells_NNS ,_, which_WDT do_VBP not_RB produce_VB IFN_NP ,_, the_DT titer_NN of_IN rNDV_NP V(-)2ch_NP was_VBD only_RB 20-fold_JJ lower_JJR than_IN of_IN that_DT of_IN wt_NP rNDV_NP ._SENT Replication_NN of_IN rNDV_NP V(-)2ch_NP was_VBD also_RB more_RBR efficient_JJ in_IN 6-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ,_, which_WDT are_VBP known_VBN to_TO be_VB IFN_NP deficient_JJ ,_, than_IN in_IN 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ._SENT Interestingly_RB ,_, both_DT wt_NP rNDV_NP and_CC rNDV_NP V(-)2ch_NP replicated_VBD poorly_RB in_IN human_JJ Hep-2_NP and_CC A549_NP cells_NNS ,_, reaching_VBG similar500-fold-lower_NN titers_NNS than_IN wt_NP rNDV_NP in_IN CEFs_NP ._SENT To_TO demonstrate_VB that_IN the_DT replication-defective_JJ phenotype_NN of_IN rNDV_NP V(-)2ch_NP was_VBD due_JJ to_TO impaired_VBN V_CD protein_NN expression_NN ,_, we_PP reinserted_VBD the_DT V_CD gene_NN as_IN an_DT additional_JJ transcriptional_JJ unit_NN between_IN the_DT HN_NP and_CC L_NP genes_NNS and_CC generated_VBD rNDV_NP V(-)/V_NP ._SENT This_DT insertion_NN improved_VBD the_DT replication_NN of_IN the_DT virus_NN to_TO levels_NNS comparable_JJ to_TO those_DT of_IN wt_JJ rNDV_NN in_IN both_DT embryonated_JJ chicken_NN eggs_NNS and_CC cell_NN cultures_NNS ,_, except_IN for_IN a_DT delayed_JJ growth_NN pattern_NN ._SENT Generation_NN of_IN an_DT NDV_NP mutant_NN expressing_VBG a_DT truncated_JJ V_CD protein_NN lacking_VBG its_PP$ C-terminal_JJ domain_NN ._SENT |_SYM It_PP has_VBZ been_VBN demonstrated_VBN that_IN plasmid-mediated_JJ expression_NN of_IN the_DT C-terminal_JJ domain_NN of_IN NDV_NP V_CD inhibits_VBZ the_DT IFN-alpha/beta_NP response_NN ._SENT To_TO selectively_RB block_VB expression_NN of_IN the_DT unique_JJ C_NP terminus_NN of_IN the_DT V_CD protein_NN in_IN an_DT infectious_JJ NDV_NP ,_, an_DT rNDV_NP mutant_NN expressing_VBG a_DT truncated_JJ V_CD protein_NN lacking_VBG its_PP$ C-terminal_JJ domain_NN [_SYM rNDV_NP V(-)stop_NP ]_SYM was_VBD generated_VBN ._SENT One_CD nucleotide_NN was_VBD changed_VBN in_IN the_DT P_NN gene_NN to_TO create_VB a_DT premature_JJ stop_NN codon_NN in_IN V_CD without_IN affecting_VBG the_DT P_NN ORF_NP ._SENT A_DT similar_JJ mutant_NN had_VBD been_VBN shown_VBN to_TO grow_VB to_TO titers_NNS even_RB lower_JJR than_IN those_DT of_IN an_DT editing-defective_JJ mutant_JJ NDV_NP ._SENT In_IN our_PP$ studies_NNS ,_, maximal_JJ titers_NNS of_IN rNDV_NP V(-)stop_NP in_IN 6-_CD or_CC 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS were_VBD also_RB similar104-fold_NN lower_JJR than_IN those_DT of_IN rNDV_NP V(-)2ch_NP ._SENT rNDV_NP V(-)stop_NP did_VBD not_RB grow_VB to_TO measurable_JJ titers_NNS in_IN CEFs_NP (_( data_NN not_RB shown_VBN )_) ._SENT These_DT results_NNS indicate_VBP that_IN the_DT C-terminal_JJ domain_NN of_IN the_DT NDV_NP V_NN protein_NN plays_VBZ a_DT critical_JJ role_NN in_IN viral_JJ replication_NN ._SENT Expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN compensates_VBZ for_IN the_DT lack_NN of_IN the_DT V_CD C-terminal_JJ domain_NN in_IN infectious_JJ NDV_NP ._SENT |_SYM In_IN order_NN to_TO study_VB the_DT contribution_NN of_IN the_DT IFN_NP antagonist_NN activity_NN of_IN the_DT C-terminal_JJ domain_NN of_IN V_CD in_IN NDV_NP replication_NN ,_, we_PP generated_VBD an_DT rNDV_NN expressing_VBG the_DT IFN_NP antagonist_NN NS1_JJ protein_NN of_IN influenza_NN A_DT virus_NN in_IN the_DT backbone_NN of_IN rNDV_NP V(-)stop_NP ._SENT The_DT NS1_NP ORF_NP was_VBD inserted_VBN into_IN pNDV_NP V(-)stop_NP between_IN the_DT HN_NP and_CC L_NP genes_NNS as_IN an_DT extra_JJ transcriptional_JJ unit_NN ._SENT Expression_NN of_IN the_DT influenza_NN virus_NN NS1_JJ protein_NN from_IN rNDV_NP V(-)/NS1-infected_NP CEFs_NP was_VBD detected_VBN using_VBG anti-influenza_NN virus_NN NS1_JJ rabbit_NN polyclonal_JJ antibody_NN ._SENT Interestingly_RB ,_, the_DT insertion_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ gene_NN into_IN the_DT rNDV_NP V(-)stop_NP genome_NN restored_VBD viral_JJ replication_NN in_IN both_DT embryonated_JJ chicken_NN eggs_NNS and_CC CEFs_NNS to_TO wt_JJ rNDV_NN levels_NNS ._SENT These_DT data_NNS indicate_VBP that_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN complements_VBZ the_DT loss_NN of_IN function_NN of_IN the_DT C-terminal_JJ domain_NN of_IN the_DT NDV_NP V_CD protein_NN in_IN the_DT context_NN of_IN infectious_JJ viruses_NNS ,_, suggesting_VBG that_IN the_DT NDV_NP V_CD and_CC the_DT influenza_NN NS1_JJ proteins_NNS are_VBP functionally_RB interchangeable_JJ IFN-alpha/beta_NP antagonists_NNS in_IN chicken_NN cells_NNS ._SENT Expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN enhances_VBZ replication_NN of_IN NDV_NP in_IN human_JJ cells_NNS ._SENT |_SYM The_DT growth_NN properties_NNS of_IN rNDV_NP V(-)/NS1_NP were_VBD also_RB analyzed_VBN in_IN human_JJ cell_NN lines_NNS ._SENT Hep-2_NP or_CC A549_NP cells_NNS were_VBD infected_VBN at_IN an_DT MOI_NP of_IN 0.01_CD ,_, and_CC viral_JJ titers_NNS in_IN the_DT supernatant_JJ were_VBD determined_VBN at_IN different_JJ times_NNS p.i._JJ Interestingly_RB ,_, titers_NNS of_IN rNDV_NP V(-)/NS1_NP were_VBD similar10-fold_NN higher_JJR than_IN those_DT of_IN rNDV_NP ,_, rNDV_NP V(-)2ch_NP ,_, or_CC rNDV_NP V(-)/V_NP in_IN both_DT human_JJ cell_NN lines_NNS ._SENT These_DT results_NNS suggest_VBP that_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN prevents_VBZ the_DT cellular_JJ antiviral_JJ response_NN more_RBR efficiently_RB than_IN the_DT NDV_NP V_CD protein_NN in_IN human_JJ cells_NNS ,_, resulting_VBG in_IN increased_VBN viral_JJ replication_NN ._SENT Therefore_RB ,_, the_DT host_NN range_NN of_IN NDV_NP for_IN avian_JJ species_NNS might_MD be_VB partly_RB explained_VBN by_IN the_DT IFN-alpha/beta_NP antagonist_NN activity_NN of_IN its_PP$ V_CD protein_NN ._SENT NDV_NP V_NN prevents_VBZ IFN_NP production_NN in_IN CEFs_NP but_CC not_RB in_IN human_JJ Hep-2_NP cells_NNS during_IN viral_JJ infection_NN ._SENT |_SYM In_IN order_NN to_TO investigate_VB whether_IN the_DT impaired_JJ replication_NN of_IN rNDV_NN mutants_NNS correlated_VBN with_IN higher_JJR levels_NNS of_IN IFN_NP induced_VBD in_IN infected_JJ cell_NN monolayers_NNS ,_, we_PP measured_VBD the_DT IFN_NP present_NN in_IN the_DT supernatants_NNS of_IN infected_JJ cells_NNS using_VBG a_DT bioassay_NN ,_, as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT In_IN these_DT experiments_NNS ,_, we_PP did_VBD not_RB use_VB rNDV_NP V(-)stop_NP because_IN this_DT virus_NN could_MD not_RB be_VB grown_VBN to_TO the_DT titers_NNS required_VBN to_TO achieve_VB an_DT MOI_NP of_IN 1_CD ._SENT Hep-2_JJ cells_NNS and_CC CEFs_NNS were_VBD infected_VBN with_IN wt_NP rNDV_NP or_CC rNDV_NP mutants_NNS at_IN an_DT MOI_NP of_IN 1_CD ._SENT Supernatants_NNS were_VBD collected_VBN 24_CD h_NN p.i._NN ,_, UV_NP treated_VBD ,_, and_CC used_VBN to_TO pretreat_JJ Vero_NP cells_NNS or_CC CEFs_NNS for_IN 20_CD h_NN before_IN challenging_VBG them_PP with_IN NDV-GFP_NP ._SENT Bioactive_NP IFN_NP present_NN in_IN the_DT samples_NNS was_VBD monitored_VBN based_VBN on_IN its_PP$ ability_NN to_TO prevent_VB NDV-GFP_NP replication_NN ,_, as_RB measured_VBN by_IN GFP_NP expression_NN ._SENT As_IN expected_VBN ,_, no_DT IFN_NP was_VBD detected_VBN in_IN IFN-deficient_NP Vero_NP cells_NNS infected_VBN with_IN any_DT of_IN the_DT rNDVs_NNS ._SENT Thus_RB ,_, when_WRB supernatants_NNS of_IN infected_JJ Vero_NP cells_NNS were_VBD added_VBN to_TO new_JJ Vero_NP cells_NNS ,_, viral_JJ replication_NN of_IN NDV-GFP_NP was_VBD not_RB inhibited_VBN ._SENT In_IN contrast_NN ,_, when_WRB Vero_NP cells_NNS were_VBD treated_VBN with_IN human_JJ IFN-beta_NP ,_, NDV-GFP_NP replication_NN was_VBD completely_RB abolished_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Similarly_RB ,_, pretreatment_NN of_IN Vero_NP cells_NNS with_IN supernatant_JJ from_IN wt_NP rNDV_NP ,_, rNDV(-)2ch_NN ,_, or_CC rNDV_NP V(-)/V-infected_NP Hep-2_NP cells_NNS induced_VBD an_DT antiviral_JJ state_NN that_WDT prevented_VBD NDV-GFP_NP replication_NN ,_, indicating_VBG that_IN all_DT three_CD viruses_NNS induced_VBD similar_JJ levels_NNS of_IN IFN_NP secretion_NN in_IN human_JJ Hep-2_NP cells_NNS ._SENT Interestingly_RB ,_, the_DT levels_NNS of_IN IFN_NP present_NN in_IN supernatants_NNS from_IN rNDV_NP V(-)/NS1-infected_NP Hep-2_NP cells_NNS was_VBD decreased_VBN similar10-fold_NN ._SENT To_TO monitor_VB levels_NNS of_IN IFN_NP secreted_VBD by_IN infected_JJ CEFs_NNS ,_, we_PP replaced_VBD Vero_NP cells_NNS with_IN the_DT homologous_JJ CEFs_NNS as_IN the_DT indicator_NN cell_NN line_NN ,_, since_IN IFN_NP from_IN one_CD species_NNS (_( chicken_NN )_) usually_RB does_VBZ not_RB recognize_VB the_DT receptor_NN of_IN a_DT distantly_RB related_VBN species_NNS (_( monkey_NN )_) ._SENT When_WRB supernatants_NNS from_IN rNDV_NP V(-)2ch-infected_NP CEFs_NP were_VBD used_VBN to_TO pretreat_NNS new_JJ CEFs_NP ,_, NDV-GFP_NP replication_NN was_VBD substantially_RB inhibited_VBN ._SENT However_RB ,_, preteatment_NN of_IN CEFs_NNS with_IN supernatants_NNS from_IN CEFs_NNS infected_VBN with_IN wt_NP rNDV_NP ,_, rNDV_NP V(-)/V_NP ,_, or_CC rNDV_NP V(-)/NS1_NP did_VBD not_RB inhibit_VB NDV-GFP_NP replication_NN ._SENT These_DT data_NNS correlate_VBP with_IN the_DT replication_NN properties_NNS of_IN rNDV_NN mutants_NNS in_IN CEFs_NP ._SENT They_PP also_RB correlate_VBP with_IN the_DT observed_JJ levels_NNS of_IN activation_NN of_IN an_DT IFN-responsive_JJ promoter_NN following_VBG infection_NN with_IN the_DT different_JJ viruses_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Taken_VBN together_RB ,_, our_PP$ results_NNS indicate_VBP that_IN the_DT NS1_JJ protein_NN of_IN influenza_NN A_DT virus_NN inhibits_VBZ IFN_NP production_NN in_IN NDV-infected_NP CEFs_NP and_CC Hep-2_NP cells_NNS ,_, while_IN the_DT NDV_NP V_NN protein_NN prevents_VBZ IFN_NP production_NN only_RB in_IN NDV-infected_NP CEFs_NP but_CC not_RB in_IN human_JJ Hep-2_NP cells_NNS ._SENT Delayed_JJ apoptosis_NN in_IN NDV-infected_JJ chicken_NN cells_NNS but_CC not_RB in_IN human_JJ cells_NNS ._SENT |_SYM When_WRB CEFs_NP were_VBD infected_VBN with_IN the_DT different_JJ rNDVs_NNS at_IN an_DT MOI_NP of_IN 1_CD ,_, we_PP observed_VBD that_DT infection_NN with_IN rNDV_NP V(-)2ch_NP showed_VBD increased_VBN CPE_NN compared_VBN to_TO CEFs_NNS infected_VBN with_IN wt_NP rNDV_NP ,_, rNDV_NP V(-)/V_NP ,_, or_CC rNDV_NP V(-)/NS1_NP at_IN 36_CD h_NN p.i._NN (_( Fig._NN ,_, top_JJ )_) ._SENT In_IN contrast_NN ,_, in_IN Hep-2_JJ cells_NNS ,_, the_DT degrees_NNS of_IN CPE_NP were_VBD similarly_RB high_JJ upon_IN infection_NN with_IN wt_NN rNDV-_NN ,_, rNDV_NP V(-)2ch-_NP ,_, or_CC rNDV_NP V(-)/V-infected_NP Hep-2_NP cells_NNS at_IN 36_CD h_NN p.i._NP rNDV_NP V(-)/NS1_NP was_VBD exceptional_JJ in_IN Hep-2_JJ cells_NNS and_CC induced_VBN low_JJ levels_NNS of_IN CPE_NP (_( Fig._NN ,_, top_JJ )_) ._SENT wt_NN rNDV-_NN ,_, rNDV_NP V(-)2ch-_NP ,_, or_CC rNDV_NP V(-)/V-infected_NP Hep-2_NP cells_NNS were_VBD detached_VBN from_IN the_DT monolayers_NNS and_CC had_VBD the_DT appearance_NN of_IN apoptotic_JJ cells_NNS ,_, while_IN rNDV_NP V(-)/NS1-infected_NP and_CC mock-infected_JJ Hep-2_NP cells_NNS had_VBD similar_JJ appearance_NN with_IN only_RB a_DT few_JJ detached_JJ cells_NNS ._SENT To_TO determine_VB whether_IN the_DT increased_VBN CPE_NN seen_VBN in_IN NDV-infected_JJ cells_NNS was_VBD indicative_JJ of_IN the_DT induction_NN of_IN apoptosis_NN ,_, Hoechst_NP 33258_CD staining_VBG was_VBD performed_VBN to_TO detect_VB chromatin_NN condensation_NN ,_, which_WDT is_VBZ one_CD of_IN the_DT hallmarks_NNS of_IN apoptosis_NN ._SENT The_DT majority_NN of_IN CEFs_NNS infected_VBN with_IN rNDV_NP V(-)2ch_NP showed_VBD chromatin_NN condensation_NN at_IN 36_CD h_NN p.i._NN in_IN this_DT assay_NN ._SENT In_IN contrast_NN ,_, low_JJ levels_NNS of_IN chromatin_NN condensation_NN ,_, similar_JJ to_TO those_DT in_IN mock-infected_JJ CEFs_NNS ,_, were_VBD observed_VBN in_IN wt_NN rNDV-_NN ,_, rNDV_NP V(-)/V-_NP ,_, or_CC rNDV_NP V(-)/NS1-infected_NP CEFs_NP (_( Fig._NN ,_, bottom_JJ )_) ._SENT On_IN the_DT other_JJ hand_NN ,_, human_JJ Hep-2_NP cells_NNS infected_VBN with_IN the_DT same_JJ rNDVs_NNS showed_VBD high_JJ levels_NNS of_IN chromatin_NN condensation_NN indicative_JJ of_IN apoptosis_NN ,_, with_IN the_DT exception_NN of_IN rNDV_NP V(-)/NS1-infected_NP cells_NNS (_( Fig._NN ,_, bottom_JJ )_) ._SENT The_DT presence_NN of_IN fragmented_JJ chromosomal_JJ DNAs_NP was_VBD also_RB analyzed_VBN in_IN infected_JJ CEFs_NP or_CC Hep-2_NP cells_NNS ._SENT Cells_NNS were_VBD harvested_VBN 36_CD h_NN p.i._NN ,_, and_CC DNA_NP was_VBD purified_VBN and_CC analyzed_VBN for_IN fragmentation_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Fragmented_JJ DNA_NN was_VBD not_RB detected_VBN in_IN rNDV-infected_JJ CEFs_NNS at_IN that_DT time_NN ._SENT However_RB ,_, infection_NN of_IN CEFs_NP by_IN rNDV_NP V(-)2ch_NP resulted_VBD in_IN clear_JJ DNA_NN fragmentation_NN ._SENT DNA_NP fragmentation_NN was_VBD also_RB apparent_JJ in_IN Hep-2_JJ cells_NNS infected_VBN by_IN wt_NP rNDV_NP ,_, rNDV_NP V(-)2ch_NP ,_, or_CC rNDV_NP V(-)/V_NP ,_, but_CC not_RB in_IN rNDV_NP V(-)/NS1-infected_NP Hep-2_NP cells_NNS ._SENT To_TO confirm_VB the_DT chromatin_NN condensation_NN and_CC DNA_NN fragmentation_NN results_NNS ,_, TUNEL_NP assays_NNS were_VBD performed_VBN ._SENT Virus-infected_JJ CEFs_NP and_CC Hep-2_NP cells_NNS were_VBD TUNEL_NP stained_VBN at_IN 24_CD and_CC 48_CD h_NN p.i._JJ to_TO detect_VB the_DT presence_NN of_IN nicked_VBN chromosomal_JJ DNA_NN ,_, as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT As_IN shown_VBN in_IN Fig._NN ,_, TUNEL-positive_NP CEFs_NP were_VBD apparent_JJ only_RB after_IN rNDV_NP V(-)2ch_NP infection_NN ,_, with_IN levels_NNS increasing_VBG from_IN 24_CD to_TO 48_CD h_NN p.i._NN By_IN contrast_NN ,_, TUNEL-positive_JJ human_JJ Hep-2_NP cells_NNS were_VBD detected_VBN following_VBG infection_NN with_IN wt_NP rNDV_NP ,_, rNDV_NP V(-)2ch_NP ,_, or_CC rNDV_NP V(-)/V_NP ,_, while_IN only_RB very_RB low_JJ levels_NNS of_IN nicked-DNA_NN staining_VBG were_VBD observed_VBN in_IN rNDV_NP V(-)/NS1-infected_NP Hep-2_NP cells_NNS and_CC only_RB at_IN 48_CD h_NN p.i._NN Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN V_CD expression_NN delays_NNS apoptosis_NN in_IN NDV-infected_NP CEFs_NP but_CC not_RB in_IN human_JJ Hep-2_NP cells_NNS ._SENT Interestingly_RB ,_, expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN by_IN NDV_NP results_NNS in_IN delayed_JJ apoptosis_NN even_RB in_IN Hep-2_JJ cells_NNS ._SENT It_PP has_VBZ been_VBN demonstrated_VBN that_IN the_DT V_CD protein_NN of_IN NDV_NP has_VBZ IFN_NP antagonist_NN activity_NN and_CC that_IN this_DT activity_NN is_VBZ associated_VBN with_IN the_DT C_NP terminus_NN of_IN the_DT protein_NN ._SENT This_DT finding_NN was_VBD based_VBN on_IN experiments_NNS in_IN which_WDT plasmids_NNS expressing_VBG the_DT entire_JJ ORF_NP of_IN V_CD or_CC the_DT C-terminal_JJ domain_NN of_IN V_CD were_VBD transfected_VBN into_IN cells_NNS ,_, and_CC the_DT replication_NN of_IN an_DT IFN-sensitive_JJ virus_NN was_VBD used_VBN as_IN a_DT readout_NN to_TO measure_VB anti-IFN_NN activity_NN ._SENT Here_RB ,_, we_PP have_VBP used_VBN reverse_JJ genetics_NNS to_TO generate_VB NDV_NP mutants_NNS which_WDT are_VBP defective_JJ in_IN the_DT expression_NN of_IN V_CD in_IN order_NN to_TO study_VB the_DT activity_NN of_IN the_DT V_CD protein_NN in_IN the_DT context_NN of_IN infectious_JJ viruses_NNS ._SENT The_DT editing-defective_JJ mutant_JJ NDV_NP V(-)2ch_NP grows_VBZ in_IN IFN-competent_JJ cells_NNS to_TO titers_NNS which_WDT are_VBP 3_CD to_TO 4_CD log_NN units_NNS lower_JJR than_IN those_DT achieved_VBN by_IN the_DT wt_JJ rNDV_NN ._SENT In_IN Vero_NP cells_NNS ,_, which_WDT are_VBP defective_JJ in_IN IFN_NP synthesis_NN ,_, the_DT growth_NN difference_NN between_IN rNDV_NP V(-)2ch_NP and_CC rNDV_NP is_VBZ less_RBR pronounced_JJ ._SENT This_DT finding_NN and_CC the_DT fact_NN that_IN an_DT isogenic_JJ recombinant_JJ NDV_NP expressing_VBG the_DT full-length_JJ V_NN as_IN a_DT separate_JJ transcriptional_JJ unit_NN has_VBZ wt-like_JJ growth_NN characteristics_NNS confirm_VBP the_DT idea_NN that_IN the_DT V_CD protein_NN provides_VBZ NDV_NP with_IN the_DT ability_NN to_TO grow_VB in_IN IFN-competent_NP CEFs_NP ._SENT More_RBR importantly_RB ,_, it_PP was_VBD found_VBN that_IN the_DT IFN_NP antagonist_NN of_IN influenza_NN A_DT viruses_NNS (_( NS1_NP )_) could_MD functionally_RB replace_VB the_DT V_CD protein_NN ._SENT In_IN an_DT NDV_NP backbone_NN which_WDT was_VBD unable_JJ to_TO express_VB the_DT C_NP terminus_NN of_IN the_DT V_CD protein_NN ,_, expression_NN of_IN the_DT NS1_JJ protein_NN resulted_VBN in_IN a_DT virus_NN [_SYM rNDV_NP V(-)/NS1_NP ]_SYM indistinguishable_JJ from_IN wt_JJ rNDV_NN with_IN respect_NN to_TO growth_NN in_IN CEFs_NP ._SENT Furthermore_RB ,_, this_DT virus_NN showed_VBD an_DT increased_JJ (_( 1.5-log-unit_JJ )_) replication_NN titer_NN in_IN human_JJ cells_NNS over_IN that_DT of_IN wt_NP rNDV_NP ._SENT This_DT finding_NN suggests_VBZ that_IN replacing_VBG the_DT V_CD protein_NN with_IN the_DT influenza_NN virus_NN NS1_JJ protein_NN enhances_VBZ the_DT ability_NN of_IN NDV_NP to_TO grow_VB in_IN human_JJ cells_NNS ._SENT Although_IN rNDV_NP V(-)/NS1_NP grows_VBZ to_TO higher_JJR titers_NNS in_IN Hep-2_NP and_CC A549_NP cells_NNS than_IN wt_NP NDV_NP ,_, the_DT absolute_JJ titers_NNS of_IN the_DT virus_NN are_VBP lower_JJR than_IN those_DT obtained_VBN in_IN CEFs_NP (_( avian_JJ cells_NNS represent_VBP the_DT natural_JJ host_NN of_IN NDV_NP )_) ._SENT We_PP showed_VBD earlier_RBR that_IN the_DT IFN_NP antagonist_NN NS1_NP may_MD influence_VB the_DT replication_NN properties_NNS of_IN a_DT virus_NN ._SENT Exchanging_VBG the_DT NS1_JJ gene_NN in_IN a_DT mouse-adapted_JJ influenza_NN virus_NN with_IN the_DT NS1_JJ gene_NN of_IN the_DT 1918_CD human_JJ pandemic_JJ influenza_NN virus_NN resulted_VBN in_IN a_DT dramatic_JJ decrease_NN in_IN replication_NN in_IN the_DT mouse_NN ,_, suggesting_VBG a_DT species-specific_JJ property_NN of_IN the_DT IFN_NP antagonist_NN NS1_NP ._SENT It_PP has_VBZ also_RB been_VBN reported_VBN that_IN the_DT SV5_NP V_CD protein_NN blocks_NNS IFN_NP signaling_VBG by_IN causing_VBG the_DT proteasomal_JJ degradation_NN of_IN the_DT transcription_NN factor_NN STAT1_NP in_IN human_JJ cells_NNS but_CC not_RB in_IN mouse_NN cells_NNS ._SENT Similarly_RB ,_, respiratory_JJ syncytial_JJ virus_NN was_VBD shown_VBN to_TO exhibit_VB host_NN range_NN restrictions_NNS mediated_VBN by_IN viral_JJ IFN_NP antagonist_NN proteins_NNS ._SENT In_IN addition_NN ,_, intracellular_JJ STAT2_NP protein_NN can_MD act_VB as_IN a_DT host_NN range_NN determinant_NN of_IN paramyxoviruses_NNS ._SENT Interestingly_RB ,_, Maeno_NP et_FW al._FW reported_VBD that_DT superinfection_NN of_IN HeLa_NP cells_NNS with_IN Sendai_NP virus_NN and_CC NDV_NP resulted_VBD in_IN the_DT complementation_NN of_IN the_DT growth_NN of_IN NDV_NP ._SENT In_IN retrospect_NN ,_, we_PP suggest_VBP that_IN the_DT enhanced_JJ yield_NN of_IN NDV_NP in_IN the_DT superinfected_JJ cultures_NNS is_VBZ the_DT result_NN of_IN the_DT expression_NN in_IN human_JJ cells_NNS of_IN functional_JJ IFN_NP antagonists_NNS by_IN Sendai_NP virus_NN ._SENT By_IN this_DT mechanism_NN ,_, the_DT host_NN restriction_NN of_IN NDV_NP in_IN human_JJ cells_NNS was_VBD alleviated_VBN ._SENT The_DT experiments_NNS reported_VBD in_IN the_DT present_JJ paper_NN show_VBP that_IN direct_JJ expression_NN of_IN the_DT influenza_NN virus_NN NS1_JJ protein_NN in_IN a_DT recombinant_JJ NDV_NP leads_VBZ to_TO a_DT similar_JJ phenotype_NN ._SENT Additional_JJ evidence_NN for_IN the_DT mechanism_NN involving_VBG IFN_NP comes_VBZ from_IN direct_JJ measurements_NNS of_IN IFN_NP secreted_VBD from_IN Hep-2_JJ cells_NNS infected_VBN with_IN these_DT recombinant_JJ viruses_NNS ._SENT Only_RB the_DT NS1-expressing_JJ virus_NN [_SYM rNDV_NP V(-)/NS1_NP ]_SYM in_IN Hep-2_JJ cells_NNS appears_VBZ to_TO suppress_VB the_DT induction_NN of_IN human_JJ IFN_NP ._SENT Hep-2_JJ cells_NNS infected_VBN by_IN other_JJ recombinant_JJ viruses_NNS ,_, including_VBG the_DT wt_NN rNDV_NN ,_, induce_VB an_DT IFN_NP response_NN which_WDT can_MD be_VB measured_VBN by_IN blocking_VBG virus_NN replication_NN in_IN Vero_NP cells_NNS ._SENT As_IN expected_VBN ,_, in_IN chicken_NN cells_NNS ,_, both_CC the_DT V_CD protein-_NN and_CC the_DT NS1_JJ protein-expressing_NN viruses_NNS suppress_VBP the_DT synthesis_NN of_IN IFN_NP ,_, again_RB demonstrating_VBG the_DT species_NN specificity_NN of_IN these_DT viral_JJ IFN_NP antagonists_NNS ._SENT The_DT ability_NN of_IN NDV_NP V_CD to_TO suppress_VB IFN_NP production_NN in_IN CEFs_NP might_MD be_VB due_JJ to_TO an_DT inhibition_NN of_IN IFN_NP regulatory_JJ factors_NNS (_( IRFs_NP )_) ,_, as_RB reported_VBN for_IN the_DT V_CD proteins_NNS of_IN SV5_NP and_CC Sendai_NP virus_NN ,_, or_CC to_TO an_DT inhibition_NN of_IN STAT_NP factors_NNS involved_VBN in_IN a_DT positive_JJ feedback_NN of_IN IFN_NP synthesis_NN ._SENT In_IN this_DT respect_NN ,_, the_DT V_CD protein_NN of_IN the_DT paramyxoviruses_NNS SV5_NP ,_, hPIV2_NN ,_, and_CC SV41_NP and_CC mumps_VBZ and_CC Nipah_NP viruses_NNS are_VBP known_VBN to_TO inhibit_VB STAT_NP function_NN ._SENT Compared_VBN to_TO rNDV_NP ,_, rNDV_NP V(-)2ch_NP exhibited_VBD an_DT increased_VBN CPE_NN in_IN chicken_NN cells_NNS ._SENT We_PP suggest_VBP that_IN this_DT effect_NN is_VBZ related_VBN to_TO an_DT antiapoptotic_JJ activity_NN of_IN the_DT viral_JJ V_CD protein_NN ._SENT Three_CD assays_NNS were_VBD used_VBN to_TO further_RBR characterize_VB this_DT finding_NN ._SENT Hoechst_NP 33258_NP staining_VBG showed_VBN condensation_NN of_IN nuclear_JJ chromatin_NN in_IN rNDV_NP V(-)2ch-infected_NP chicken_NN cells_NNS ._SENT DNA_NP fragmentation_NN analysis_NN and_CC TUNEL_NP assays_NNS confirmed_VBD the_DT differences_NNS found_VBN in_IN cells_NNS infected_VBN by_IN the_DT NDV_NP mutant_NN defective_JJ in_IN V_CD compared_VBN to_TO those_DT infected_VBN by_IN viruses_NNS expressing_VBG V_CD or_CC NS1_NP ._SENT In_IN human_JJ cells_NNS ,_, however_RB ,_, infection_NN by_IN rNDV_NP V(-)2ch_NP is_VBZ very_RB similar_JJ to_TO that_DT by_IN viruses_NNS expressing_VBG V_CD protein_NN with_IN respect_NN to_TO chromatin_NN condensation_NN ,_, DNA_NN fragmentation_NN ,_, and_CC TUNEL_NP assays_NNS ._SENT Only_RB the_DT NDV_NP recombinant_JJ expressing_VBG the_DT NS1_JJ protein_NN appears_VBZ to_TO cause_VB CPE_NN without_IN apoptotic_JJ changes_NNS ._SENT In_IN our_PP$ experiments_NNS using_VBG the_DT NDV_NP Hitchner_NP B1_NP strain_NN ,_, we_PP did_VBD not_RB observe_VB a_DT significant_JJ level_NN of_IN apoptotic_JJ markers_NNS in_IN infected_JJ CEFs_NNS ._SENT This_DT appears_VBZ to_TO be_VB inconsistent_JJ with_IN an_DT earlier_JJR report_NN by_IN Lam_NP ,_, who_WP found_VBD apoptosis_NN in_IN chicken_NN embryo_NN cells_NNS 12_CD h_NN p.i._NN by_IN the_DT GB_NP strain_NN of_IN NDV_NP ._SENT This_DT strain_NN of_IN NDV_NP is_VBZ highly_RB virulent_JJ ,_, and_CC thus_RB ,_, cells_NNS may_MD undergo_VB a_DT stress-related_JJ response_NN to_TO infection_NN ._SENT In_IN accord_NN with_IN our_PP$ results_NNS ,_, NDV_NP has_VBZ been_VBN reported_VBN to_TO be_VB an_DT excellent_JJ inducer_NN of_IN IFN-alpha_NP and_CC of_IN tumor_NN necrosis_NN factor_NN alpha_NN in_IN both_DT mouse_NN and_CC human_JJ macrophages_NNS and_CC lymphocytes_NNS ._SENT Also_RB ,_, the_DT expression_NN of_IN TRAIL_NP (_( tumor_NN necrosis_NN factor-related_JJ apoptosis-inducing_NN ligand_NN )_) (_( and_CC thus_RB of_IN apoptosis_NN )_) was_VBD induced_VBN by_IN NDV_NP in_IN human_JJ monocytes_NNS ._SENT Several_JJ reports_NNS have_VBP demonstrated_VBN that_IN IFN-alpha/beta_NP and_CC IFN-gamma_NP induce_VB apoptosis_NN in_IN human_JJ tumor_NN cells_NNS ._SENT NDV_NP infection_NN of_IN human_JJ tumor_NN cells_NNS can_MD lead_VB to_TO the_DT upregulation_NN of_IN HLA_NP ,_, cell_NN adhesion_NN molecules_NNS ,_, and_CC chemokines_NNS and_CC ,_, finally_RB ,_, to_TO apoptosis_NN ._SENT It_PP is_VBZ not_RB clear_JJ whether_IN the_DT antiapoptotic_JJ activity_NN of_IN the_DT NDV_NP V_NN protein_NN is_VBZ mediated_VBN by_IN its_PP$ IFN_NP antagonist_NN activity_NN ._SENT Further_JJR experiments_NNS are_VBP required_VBN to_TO clarify_VB this_DT issue_NN ._SENT Interestingly_RB ,_, mutations_NNS in_IN the_DT V_CD gene_NN of_IN SV5_NP can_MD also_RB result_VB in_IN viruses_NNS that_WDT induce_VBP both_DT IFN_NN and_CC cell_NN death_NN ._SENT In_IN terms_NNS of_IN the_DT antiapoptotic_JJ activity_NN of_IN the_DT NS1_JJ protein_NN expressed_VBN by_IN infectious_JJ NDV_NP ,_, previous_JJ experiments_NNS involving_VBG infectious_JJ influenza_NN virus_NN expressing_VBG a_DT full-length_JJ NS1_JJ protein_NN support_VB this_DT notion_NN ._SENT However_RB ,_, there_EX is_VBZ one_CD report_NN which_WDT suggests_VBZ that_IN apoptosis_NN is_VBZ stimulated_VBN by_IN the_DT influenza_NN virus_NN NS1_JJ protein_NN when_WRB it_PP is_VBZ expressed_VBN by_IN plasmids_NNS in_IN the_DT absence_NN of_IN infectious_JJ virus_NN ._SENT Adaptation_NN of_IN a_DT virus_NN to_TO its_PP$ host_NN is_VBZ a_DT complex_JJ phenomenon_NN and_CC is_VBZ the_DT result_NN of_IN a_DT balancing_VBG act_NN involving_VBG direct_JJ interactions_NNS of_IN virus_NN and_CC host_NN components_NNS ._SENT With_IN respect_NN to_TO NDV_NP ,_, several_JJ features_NNS have_VBP been_VBN shown_VBN to_TO affect_VB the_DT growth_NN and_CC virulence_NN of_IN the_DT virus_NN in_IN its_PP$ host_NN ._SENT Specifically_RB ,_, the_DT cleavage_NN site_NN of_IN the_DT NDV_NP F_NN protein_NN has_VBZ been_VBN found_VBN to_TO be_VB an_DT important_JJ factor_NN contributing_VBG to_TO the_DT pathogenesis_NN of_IN the_DT virus_NN ._SENT We_PP suggest_VBP here_RB that_IN the_DT V_CD protein_NN is_VBZ an_DT additional_JJ virulence_NN factor_NN of_IN NDV_NP that_WDT affects_VBZ the_DT IFN_NN and_CC apoptosis_NN responses_NNS of_IN the_DT infected_JJ host_NN ._SENT Furthermore_RB ,_, we_PP suggest_VBP that_IN the_DT V_CD protein_NN affects_VBZ the_DT host_NN range_NN of_IN the_DT virus_NN via_IN its_PP$ species-specific_JJ IFN_NP antagonist_NN activity_NN ._SENT Schematic_JJ representation_NN of_IN rNDV_NN mutants_NNS ._SENT Schematic_JJ representation_NN of_IN rNDV_NN mutants_NNS ._SENT The_DT P_NN and_CC V_CD mRNAs_NNS expressed_VBN from_IN wt_NP NDV_NP are_VBP indicated_VBN at_IN the_DT top_NN ._SENT The_DT P_NN and_CC V_NN mRNAs_NNS are_VBP identical_JJ except_IN for_IN one_CD nontemplated_JJ G_NP nucleotide_NN in_IN the_DT V_CD mRNA_NN ._SENT The_DT amino_NN acids_NNS encoded_VBN by_IN the_DT indicated_JJ nucleotide_NN sequences_NNS are_VBP also_RB shown_VBN ._SENT Amino_NN acids_NNS in_IN italics_NNS show_VBP coding_VBG differences_NNS in_IN the_DT P_NN and_CC V_CD proteins_NNS due_JJ to_TO mRNA_NNS editing_VBG ._SENT Mutations_NNS introduced_VBN into_IN rNDV_NP V(-)2ch_NP are_VBP indicated_VBN by_IN a_DT solid_JJ triangle_NN ._SENT The_DT mutation_NN introduced_VBN into_IN rNDV_NP V(-)stop_NP is_VBZ also_RB indicated_VBN by_IN a_DT circled_VBN "_`` stop_VB ._SENT "_'' rNDV_NP V(-)2ch_NP is_VBZ deficient_JJ in_IN expression_NN of_IN V_CD and_CC W_NP proteins_NNS due_JJ to_TO an_DT impairment_NN in_IN RNA_NP editing_VBG ._SENT To_TO selectively_RB block_VB the_DT expression_NN of_IN the_DT carboxy_JJ terminus_NN of_IN the_DT V_CD protein_NN ,_, a_DT stop_NN codon_NN was_VBD created_VBN in_IN the_DT V_CD ORF_NP without_IN affecting_VBG the_DT P_NN frame_NN in_IN rNDV_NP V(-)stop_NP ._SENT The_DT NDV_NP V_CD or_CC the_DT influenza_NN virus_NN (_( Flu_NP )_) PR8_NP NS1_NP gene_NN was_VBD inserted_VBN between_IN the_DT HN_NP and_CC L_NP genes_NNS in_IN the_DT context_NN of_IN rNDV_NP V(-)2ch_NP or_CC rNDV_NP V(-)stop_NP ,_, respectively_RB ,_, to_TO generate_VB rNDV_NP V(-)/V_NP and_CC rNDV_NP V(-)/NS1_NP ._SENT For_IN details_NNS ,_, see_VBP Materials_NPS and_CC Methods_NP ._SENT Growth_NN kinetics_NNS of_IN rNDV_NN mutants_NNS ._SENT Growth_NN kinetics_NNS of_IN rNDV_NN mutants_NNS ._SENT CEFs_NP and_CC Vero_NP ,_, Hep-2_NP ,_, and_CC A549_NP cells_NNS were_VBD infected_VBN with_IN each_DT indicated_JJ virus_NN at_IN an_DT MOI_NP of_IN 0.01_CD in_IN the_DT presence_NN of_IN 10_CD %_NN allantoic_JJ fluid_NN ._SENT In_IN addition_NN ,_, 10-day-old_JJ embryonated_JJ chicken_NN eggs_NNS were_VBD inoculated_VBN with_IN 100_CD TCID50/egg_NN ._SENT Each_DT supernatant_JJ from_IN infected_JJ cells_NNS and_CC embryonated_JJ eggs_NNS was_VBD harvested_VBN every_DT 24_CD h_NN for_IN 3_CD days_NNS ._SENT Titers_NNS were_VBD determined_VBN by_IN measuring_VBG the_DT TCID50_NP in_IN Vero_NP cells_NNS ._SENT Note_NN that_IN the_DT mutations_NNS responsible_JJ for_IN the_DT loss_NN of_IN the_DT V_CD function_NN in_IN rNDV_NP V(-)/V_NP and_CC rNDV_NP V(-)/NS1_NP are_VBP due_JJ to_TO the_DT insertion_NN of_IN an_DT editing_VBG mutation_NN and_CC a_DT stop_NN codon_NN ,_, respectively_RB ._SENT Expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN by_IN rNDV_NP V(-)/NS1_NP ._SENT Expression_NN of_IN the_DT influenza_NN A_DT virus_NN NS1_JJ protein_NN by_IN rNDV_NP V(-)/NS1_NP ._SENT Expression_NN of_IN the_DT influenza_NN virus_NN NS1_JJ protein_NN or_CC of_IN NDV_NP viral_JJ proteins_NNS was_VBD detected_VBN in_IN infected_JJ CEFs_NNS by_IN immunofluorescence_NN using_VBG anti-rabbit_JJ influenza_NN virus_NN NS1_JJ polyclonal_JJ antibody_NN or_CC anti-rabbit_JJ NDV_NP polyclonal_JJ antibody_NN ,_, respectively_RB ._SENT Magnification_NN ,_, x10_NN ._SENT IFN_NN production_NN by_IN rNDV_NP mutant-infected_JJ cells_NNS ._SENT IFN_NN production_NN by_IN rNDV_NP mutant-infected_JJ cells_NNS ._SENT To_TO measure_VB IFN_NP production_NN after_IN viral_JJ infection_NN ,_, cells_NNS were_VBD infected_VBN with_IN rNDV_NP or_CC rNDV_NP mutants_NNS at_IN an_DT MOI_NP of_IN 1_CD ._SENT Supernatants_NP (_( Sup_NP )_) from_IN infected_JJ cells_NNS were_VBD harvested_VBN 24_CD h_NN p.i._NN and_CC then_RB treated_VBN with_IN UV_NP 